Debt-to-equity of Corbus Pharmaceuticals Holdings, Inc. from 30 Jun 2015 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2015 to 31 Dec 2025.
  • Corbus Pharmaceuticals Holdings, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 14%, a 15% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Corbus Pharmaceuticals Holdings, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 14% -2.4% -15% 31 Dec 2025
Q3 2025 12% -16% -57% 30 Sep 2025
Q2 2025 10% -48% -83% 30 Jun 2025
Q1 2025 12% -122% -91% 31 Mar 2025
Q4 2024 16% -709% -98% 31 Dec 2024
Q3 2024 28% -206% -88% 30 Sep 2024
Q2 2024 59% -75% -56% 30 Jun 2024
Q1 2024 134% +40% +42% 31 Mar 2024
Q4 2023 725% +654% +917% 31 Dec 2023
Q3 2023 234% +172% +277% 30 Sep 2023
Q2 2023 133% +76% +132% 30 Jun 2023
Q1 2023 94% +39% +69% 31 Mar 2023
Q4 2022 71% +16% +30% 31 Dec 2022
Q3 2022 62% -3.6% -5.4% 30 Sep 2022
Q2 2022 57% -31% -35% 30 Jun 2022
Q1 2022 56% -48% -46% 31 Mar 2022
Q4 2021 55% -93% -63% 31 Dec 2021
Q3 2021 66% -124% -65% 30 Sep 2021
Q2 2021 89% -74% -45% 30 Jun 2021
Q1 2021 104% -48% -32% 31 Mar 2021
Q4 2020 148% +6.9% +4.9% 31 Dec 2020
Q3 2020 190% +85% +81% 30 Sep 2020
Q2 2020 162% +79% +95% 30 Jun 2020
Q1 2020 152% +85% +129% 31 Mar 2020
Q4 2019 141% +108% +321% 31 Dec 2019
Q3 2019 105% +80% +331% 30 Sep 2019
Q2 2019 83% +64% +319% 30 Jun 2019
Q1 2019 66% +49% +274% 31 Mar 2019
Q4 2018 34% +16% +93% 31 Dec 2018
Q3 2018 24% +0.23% +0.96% 30 Sep 2018
Q2 2018 20% -8.5% -30% 30 Jun 2018
Q1 2018 18% -15% -46% 31 Mar 2018
Q4 2017 17% -36% -67% 31 Dec 2017
Q3 2017 24% -18% -42% 30 Sep 2017
Q2 2017 28% -5.8% -17% 30 Jun 2017
Q1 2017 33% -6% -15% 31 Mar 2017
Q4 2016 53% +23% +78% 31 Dec 2016
Q3 2016 42% +20% +91% 30 Sep 2016
Q2 2016 34% +15% +77% 30 Jun 2016
Q1 2016 39% 31 Mar 2016
Q4 2015 30% 31 Dec 2015
Q3 2015 22% 30 Sep 2015
Q2 2015 19% 30 Jun 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.